🔗 Visit the ClinicalTrials.gov page for NCT00409292
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer. | J Clin Oncol | 2008 | 2.04 |
| 2 | Role of cancer stem cells in pancreatic ductal adenocarcinoma. | Nat Rev Clin Oncol | 2009 | 0.99 |
| 3 | Novel agents for advanced pancreatic cancer. | Oncotarget | 2015 | 0.86 |
| 4 | The mTOR pathway in obesity driven gastrointestinal cancers: Potential targets and clinical trials. | BBA Clin | 2015 | 0.75 |